Literature DB >> 28394187

Using critical realistic evaluation to support translation of research into clinical practice.

Michelle C Swift1,2, Marilyn Langevin2, Alexander M Clark3.   

Abstract

A challenge that speech-language pathologists (SLPs) face is the translation of research into clinical practice. While randomised controlled trials (RCTs) are often touted as the "gold standard" of efficacy research, much valuable information is lost through the process; RCTs by nature are designed to wash out individual client factors and contexts that might influence the outcome in order to present the "true" impact of the intervention. However, in the area of behavioural interventions, the interaction of client factors and contexts with the treatment agent can substantially influence the outcome. This paper provides an overview of the theoretical background and methods involved in critical realistic evaluation (CRE) and discusses its current and potential application to speech-language pathology. CRE is based on the premise that a behavioural intervention cannot be evaluated without considering the context in which it was provided. While the ways in which contextual aspects and treatment mechanisms interact may seem endless, CRE methodology attempts to operationalise them into hypotheses to be empirically tested. Research based on these principles has the potential to support clinical translation of research outcomes and reduce the costs of unsuccessful treatment attempts for SLPs, clients and the service provider.

Keywords:  critical realism; evidence-based practice; realistic evaluation; speech-language pathology; stuttering; translational research

Mesh:

Year:  2017        PMID: 28394187     DOI: 10.1080/17549507.2017.1309067

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  1 in total

1.  Collaboration between parents and SLTs produces optimal outcomes for children attending speech and language therapy: Gathering the evidence.

Authors:  Inge S Klatte; Rena Lyons; Karen Davies; Sam Harding; Julie Marshall; Cristina McKean; Sue Roulstone
Journal:  Int J Lang Commun Disord       Date:  2020-05-08       Impact factor: 3.020

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.